Copyright
©The Author(s) 2023.
World J Cardiol. Jun 26, 2023; 15(6): 293-308
Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.293
Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.293
Gene name | Forward | Reverse |
TDO2 | AACATGCTCAAGGTGATAGCTC | GAACCGAGAACTGCTGTACCA |
SULF1 | TGTGTTCCACCGTTCGGTC | CACATCCTGGTCGTCAGTGAG |
KCNN4 | GCTCAACCAAGTCCGCTTC | GTGATCGGAATCAGCCACAGT |
COL3A1 | CTGTAACATGGAAACTGGGGAAA | CCATAGCTGAACTGAAAACCACC |
HSD17B6 | GGAGCGTGTTGGAGACAGAG | GAGGTTCACTTGAAAGATAGGCA |
KCNMA1 | TCACGGAACTCGCTAAGCC | AATGTGCGTCCCACTGTTTTT |
KCNMB4 | ACCAACCCCAAGTGCTCCTAT | GAATGGCTGGGAACCGATCTC |
ALDH1A3 | ATCAACAACGACTGGCACGAA | CACATCGGGCTTATCTCCTTC |
SDR16C5 | TTGAGTGTTTTGGAGGCCCTA | AACTGCAATGCTAAGAGCCTT |
18S | GTAACCCGTTGAACCCCATT | CCATCCAATCGGTAGTAGCG |
- Citation: Wang R, Yang YM. Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of TDO2 as a potential therapeutic target. World J Cardiol 2023; 15(6): 293-308
- URL: https://www.wjgnet.com/1949-8462/full/v15/i6/293.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i6.293